Lin ZHA, Shi-bin FENG, Qian-wei LI. Progress of study on the molecular imaging and targeted therapy in CD20 of non-Hodgkin's lymphoma[J]. Int J Radiat Med Nucl Med, 2010, 34(5): 269-273. DOI: 10.3760/cma.j.issn.1673-4114.2010.05.004
Citation: Lin ZHA, Shi-bin FENG, Qian-wei LI. Progress of study on the molecular imaging and targeted therapy in CD20 of non-Hodgkin's lymphoma[J]. Int J Radiat Med Nucl Med, 2010, 34(5): 269-273. DOI: 10.3760/cma.j.issn.1673-4114.2010.05.004
shu

Progress of study on the molecular imaging and targeted therapy in CD20 of non-Hodgkin's lymphoma

    Abstract
  • The molecular imaging and targeted therapy with radiolabeled anti-CD20 monoclonal antibody or recombinant anti-CD20 monoclonal antibody fragments is the effective methods to improve the survival rate for non-Hodgkin's lymphoma(NHL).This article reviews the biological characteristics of CD20 and the immunotherapy, radioimmunotherapy, radioimmunoimaging with anti-CD20 monoclonal antibody for NHL.
    • FullText(HTML)
  • loading
    • References (24)
    • Relative Articles
  • Supplements (0)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return